Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 26.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,177 shares of the medical equipment provider's stock after selling 1,829 shares during the quarter. Harbor Capital Advisors Inc.'s holdings in Intuitive Surgical were worth $2,564,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of ISRG. Tounjian Advisory Partners LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $5,152,000. Pallas Capital Advisors LLC lifted its position in shares of Intuitive Surgical by 2.1% in the first quarter. Pallas Capital Advisors LLC now owns 1,663 shares of the medical equipment provider's stock valued at $824,000 after acquiring an additional 34 shares in the last quarter. Portside Wealth Group LLC boosted its stake in shares of Intuitive Surgical by 22.5% during the first quarter. Portside Wealth Group LLC now owns 1,661 shares of the medical equipment provider's stock valued at $823,000 after acquiring an additional 305 shares during the last quarter. Moss Adams Wealth Advisors LLC increased its position in Intuitive Surgical by 23.3% during the 1st quarter. Moss Adams Wealth Advisors LLC now owns 884 shares of the medical equipment provider's stock worth $438,000 after purchasing an additional 167 shares in the last quarter. Finally, NewSquare Capital LLC raised its stake in Intuitive Surgical by 51.2% in the 1st quarter. NewSquare Capital LLC now owns 186 shares of the medical equipment provider's stock valued at $92,000 after purchasing an additional 63 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently commented on ISRG. Evercore ISI lowered their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. Piper Sandler dropped their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Robert W. Baird decreased their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Finally, Barclays cut their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $588.95.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded down $9.41 during mid-day trading on Thursday, hitting $513.00. 2,390,381 shares of the company traded hands, compared to its average volume of 1,668,728. The firm's 50 day simple moving average is $524.49 and its 200 day simple moving average is $538.83. The firm has a market cap of $183.87 billion, a P/E ratio of 80.03, a PEG ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter last year, the firm posted $1.50 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares of the company's stock, valued at $3,312,920. This trade represents a 27.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president now directly owns 907 shares in the company, valued at $510,740.77. The trade was a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock worth $2,611,577 in the last quarter. 0.70% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.